Bahram Bob Valamehr

Bahram Bob Valamehr is a seasoned professional in the field of research and development, currently serving as Chief Research & Development Officer at Fate Therapeutics Inc. Prior to this role, Valamehr held the position of Vice President of Cancer Immunotherapy at Amgen and began their career as an Associate in Research and Development. Valamehr earned a PhD in Molecular & Medical Pharmacology with a focus on Embryonic Stem Cell Research from UCLA, where studies were completed from 2004 to 2009. Additionally, Valamehr holds an MBA in Global Business from Pepperdine Graziadio Business School, completed between 2002 and 2008.